Heterozygous ASXL1 mutations that occur in earlier exons have been documented in primary chronic myelomonocytic leukemia samples (Abdel-Wahab et al., 2011), suggesting that this subset have true loss of one allele, and thus that haploinsufficiency also can contribute to the onset of hematologic malignancy. The gene discussed is ASXL1; the disease is cancer.